Cultural and Genetic Diversity in America: The Need for Individualized Pharmaceutical Treatment
Authors: Burroughs, VJ; Maxey, RW; Crawley, LM; Levy, RA.
Publication: October 2002
Size: 32 pages (PDF)
Pharmacogenetic research in the past few decades has uncovered significant differences among population groups in the metabolism, clinical effectiveness, and side effect profiles of many clinically important drugs. In addition, differences in how various populations view and respond to medicines underscores the need for an individualized approach to pharmaceutical therapy. Historically, the special needs and responses to pharmaceutical treatment of these groups have been undervalued or ignored. According to the authors, all of these factors must be taken into account in the design of cost management policies such as formulary management, therapeutic drug substitution, and step-care protocols. These programs should be broad and flexible enough to enable rational choices and individualized treatment for all patients, regardless of racial or ethnic origin.
Want to learn more about NPC?
2012 Annual Report.
1717 Pennsylvania Ave., NW
Washington, DC 20006
Follow NPC News
Keep up to date with NPC news and events by signing up for our e-newsletter, E.V.I.dently, and our CER Daily Newsfeed.
Media requests only, please contact Andrea Hofelich at 202-827-2078.